The Scientist - Home

Among scientists, Joachim Messing, in his excellent commentary (The Scientist, June 27, 1994, page 13), made the case for supporting many small, rather than a few large, projects. Some excellent suggestions on improvements have also been proposed by Jose M. Musacchio, though he, too, refrains from suggesting major changes in the peer-review system (FASEB Journal, 8:679-83, 1994). Of all the information recently brought out on spons

Cancer Researcher For 'Crazy Ideas' AUTHOR: NEERAJA SANKARAN, pp.23 AUTHOR:BARBARA SPECTOR, pp.23 DATE: December 12, 1994 Cancer Researcher For 'Crazy Ideas' Author : NEERAJA SANKARAN, pp.23 Date: December 12, 1994 Beatrice Mintz, a senior member of the Institute for Cancer Research at the Fox Chase Cancer Center in Philadelphia, was presented with the John Scott Award during a reception on November 18 at the American Philosophi

But, just as antibodies are finding increasing utility in cell biology, a new Food and Drug Administration classification for those products with clinical utility may affect researchers' access to the important technology (see accompanying story). Monoclonal History MAbs were born in 1975, when Georges Kohler and Cesar Milstein at the Medical Research Council Laboratories in Cambridge, England, fused two types of cells to form a hy

Date : December 12, 1994 Back To: Pharmaceutical Companies Stress Innovative Research For Success The Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association of research-based pharmaceutical companies, reports an almost 15 percent reduction in the overall work force in the past two to three years, with current employment totaling 266,000. 19900 19912,700 19925,950 199324,850 199412,880 TOTAL46,380 Ma

Sidebar:A New Look For Summary Statements Sidebar: What is Triage? The expanded use of triage--under which certain grant applications deemed to be "noncompetitive" (NC) are not discussed in study sections--by the National Institutes of Health Division of Research Grants (DRG) has met with enthusiasic response from many NIH administrators. The new system, however, has engendered controversy in the extramural community. NIH welcomes

The moratorium on human embryo research coincided with the Republican presidencies of Ronald Reagan and George Bush. Both administrations opposed abortion, with support from some conservative political and religious groups, based on the view that human life begins when the ovum is fertilized and that the resulting embryo has legal rights to protection similar to those of an infant, child, or adult. In recent years, the Bush administ

Back To: Science Community Gives Mixed Reviews To 'Triage' The National Institutes of Health announced in the September 23 NIH Guide for Grants and Contracts that it will extend its use of a triage system to all investigator-initiated research grant (R01) and "FIRST Award" (First Independent Research Support and Transition Award, R29) applications submitted for October/November 1, 1994 receipt dates and reviewed by the NIH

Back To:Science Community Gives Mixed Review To 'Triage' Summary statements for National Institutes of Health grant applications (often referred to as "pink sheets," although they have not been printed on pink paper since 1991) will be formatted differently from now on: Summary statements will consist primarily of the individual reviewers' critiques. Scientific review administrators (SRAs) will write summaries of the s

Bassam Shakhashiri, a professor of chemistry at the University of Wisconsin, Madison, who was assistant director for science and engineering education at the National Science Foundation from 1984 to 1990, contends that industry involvement in this effort is more than a welcome contribution; it is a necessity. "The business community must be involved intimately in the science education reform arena because they have expertise that ac

Advanced Biotechnologies Inc. Columbia, MD Advanced Genetic Technologies Corp San Diego, CA Ahlstrom Filtration Inc. Mount Holly Springs, PA American Bioanalytical Inc. Natick, MA Boehringer Mannheim Corp. Indianapolis, IN P.J. Cobert Associates St. Louis, MO Crescent Chemical Inc. Hauppauge, NY DuPont NEN Boston, MA Fluka Chemical Corp. Ronkonkoma, NY Gallard-Schlesinger Industries Inc. Carle Place, NY Hoefer Scientific

Back to:New Funds Possible for Embryo Research The ethical reasoning of the panel advising the National Institutes of Health on human embryo research was clearly expressed by its policy cochairwoman at a news conference at which the group's report was released in September. "The basic finding of the panel is that it is acceptable public policy to fund research on the human embryo, subject to stringent guidelines," said Pa

Colleagues Laud 1994 Nobelists As Overdue For Coveted Prize Author: Edward R. Silverman Date: November 28, 1994 Colleagues of the recently announced winners of the 1994 Nobel Prizes in chemistry, physics, and medicine or physiology, in praising the decisions of the Nobel committee, say the coveted Swedish honor is long overdue for each of this year's recipients. For their part, the winners are using their newfound re